A Look into COVID-19's Impacts on China's Life Sciences Industry
The event will be conducted in Mandarin.
Event Details
In today's event, we will cover below topics:
1. COVID-19's impacts on industry performance in China and outlook
2. COVID-19's impacts on funding environment and foreign investment in China
3. Companies reaction to COVID-19 in areas from R&D, supply chain to commercial and key learnings
4. How companies rethink their strategies in China and what changes could be expected
5. China's position in global markets post-COVID
Online Webinar Agenda
3:00-3:10 Welcome and Remarks: Jasmine Kuo, '15, Chicago Booth Alumni Club of China (Shanghai Chapter) Life Science Committee
3:10-3:35 Covid's Impact on China's Life Science Industry: Brian Mi, '00, President, IQVIA Asia
3:35-4:35 Panel Discussion
Adam Sun, '98 Founding Partner, Oceanpine HC Fund
Alex Gu, '00, SVP and President Medtronic China
Jun Bao, '99, President & CEO, IMPACT Therapeutics
Yang Wang, '17, President, Medline Asia
PC Zhu, '11, ATLATL CEO
4:35-4:45 Closing Remarks: Jasmine Kuo, '15, Chicago Booth Alumni Club of China (Shanghai Chapter) Life Science Committee